Table of Content

1 Report Overview
1.1 Insulin Like Growth Factor I Definition
1.2 Market by Type
1.2.1 Global Insulin Like Growth Factor I Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 CIGB-845
1.2.3 Dusigitumab
1.2.4 GM-6
1.2.5 M-610.27
1.2.6 M-630
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Insulin Like Growth Factor I Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Alzheimer's Disease
1.3.3 Breast Cancer
1.3.4 Huntington Disease
1.3.5 Muscular Dystrophy
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Insulin Like Growth Factor I Sales
2.1 Global Insulin Like Growth Factor I Revenue Estimates and Forecasts 2018-2034
2.2 Global Insulin Like Growth Factor I Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Insulin Like Growth Factor I Revenue by Region
2.3.1 Global Insulin Like Growth Factor I Revenue by Region (2018-2023)
2.3.2 Global Insulin Like Growth Factor I Revenue by Region (2024-2034)
2.4 Global Insulin Like Growth Factor I Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Insulin Like Growth Factor I Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Insulin Like Growth Factor I Sales Quantity by Region
2.6.1 Global Insulin Like Growth Factor I Sales Quantity by Region (2018-2023)
2.6.2 Global Insulin Like Growth Factor I Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Insulin Like Growth Factor I Sales Quantity by Manufacturers
3.1.1 Global Insulin Like Growth Factor I Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Insulin Like Growth Factor I Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Insulin Like Growth Factor I Sales in 2024
3.2 Global Insulin Like Growth Factor I Revenue by Manufacturers
3.2.1 Global Insulin Like Growth Factor I Revenue by Manufacturers (2018-2023)
3.2.2 Global Insulin Like Growth Factor I Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Like Growth Factor I Revenue in 2024
3.3 Global Insulin Like Growth Factor I Sales Price by Manufacturers
3.4 Global Key Players of Insulin Like Growth Factor I, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Insulin Like Growth Factor I Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Insulin Like Growth Factor I, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Insulin Like Growth Factor I, Product Offered and Application
3.8 Global Key Manufacturers of Insulin Like Growth Factor I, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Insulin Like Growth Factor I Sales Quantity by Type
4.1.1 Global Insulin Like Growth Factor I Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Insulin Like Growth Factor I Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Insulin Like Growth Factor I Sales Quantity Market Share by Type (2018-2034)
4.2 Global Insulin Like Growth Factor I Revenue by Type
4.2.1 Global Insulin Like Growth Factor I Historical Revenue by Type (2018-2023)
4.2.2 Global Insulin Like Growth Factor I Forecasted Revenue by Type (2024-2034)
4.2.3 Global Insulin Like Growth Factor I Revenue Market Share by Type (2018-2034)
4.3 Global Insulin Like Growth Factor I Price by Type
4.3.1 Global Insulin Like Growth Factor I Price by Type (2018-2023)
4.3.2 Global Insulin Like Growth Factor I Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Insulin Like Growth Factor I Sales Quantity by Application
5.1.1 Global Insulin Like Growth Factor I Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Insulin Like Growth Factor I Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Insulin Like Growth Factor I Sales Quantity Market Share by Application (2018-2034)
5.2 Global Insulin Like Growth Factor I Revenue by Application
5.2.1 Global Insulin Like Growth Factor I Historical Revenue by Application (2018-2023)
5.2.2 Global Insulin Like Growth Factor I Forecasted Revenue by Application (2024-2034)
5.2.3 Global Insulin Like Growth Factor I Revenue Market Share by Application (2018-2034)
5.3 Global Insulin Like Growth Factor I Price by Application
5.3.1 Global Insulin Like Growth Factor I Price by Application (2018-2023)
5.3.2 Global Insulin Like Growth Factor I Price Forecast by Application (2024-2034)
6 North America
6.1 North America Insulin Like Growth Factor I Sales by Company
6.1.1 North America Insulin Like Growth Factor I Revenue by Company (2018-2023)
6.1.2 North America Insulin Like Growth Factor I Sales Quantity by Company (2018-2023)
6.2 North America Insulin Like Growth Factor I Market Size by Type
6.2.1 North America Insulin Like Growth Factor I Sales Quantity by Type (2018-2034)
6.2.2 North America Insulin Like Growth Factor I Revenue by Type (2018-2034)
6.3 North America Insulin Like Growth Factor I Market Size by Application
6.3.1 North America Insulin Like Growth Factor I Sales Quantity by Application (2018-2034)
6.3.2 North America Insulin Like Growth Factor I Revenue by Application (2018-2034)
6.4 North America Insulin Like Growth Factor I Market Size by Country
6.4.1 North America Insulin Like Growth Factor I Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Insulin Like Growth Factor I Revenue by Country (2018-2034)
6.4.3 North America Insulin Like Growth Factor I Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Insulin Like Growth Factor I Sales by Company
7.1.1 Europe Insulin Like Growth Factor I Sales Quantity by Company (2018-2023)
7.1.2 Europe Insulin Like Growth Factor I Revenue by Company (2018-2023)
7.2 Europe Insulin Like Growth Factor I Market Size by Type
7.2.1 Europe Insulin Like Growth Factor I Sales Quantity by Type (2018-2034)
7.2.2 Europe Insulin Like Growth Factor I Revenue by Type (2018-2034)
7.3 Europe Insulin Like Growth Factor I Market Size by Application
7.3.1 Europe Insulin Like Growth Factor I Sales Quantity by Application (2018-2034)
7.3.2 Europe Insulin Like Growth Factor I Revenue by Application (2018-2034)
7.4 Europe Insulin Like Growth Factor I Market Size by Country
7.4.1 Europe Insulin Like Growth Factor I Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Insulin Like Growth Factor I Revenue by Country (2018-2034)
7.4.3 Europe Insulin Like Growth Factor I Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Insulin Like Growth Factor I Sales by Company
8.1.1 China Insulin Like Growth Factor I Sales Quantity by Company (2018-2023)
8.1.2 China Insulin Like Growth Factor I Revenue by Company (2018-2023)
8.2 China Insulin Like Growth Factor I Market Size by Type
8.2.1 China Insulin Like Growth Factor I Sales Quantity by Type (2018-2034)
8.2.2 China Insulin Like Growth Factor I Revenue by Type (2018-2034)
8.3 China Insulin Like Growth Factor I Market Size by Application
8.3.1 China Insulin Like Growth Factor I Sales Quantity by Application (2018-2034)
8.3.2 China Insulin Like Growth Factor I Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Insulin Like Growth Factor I Sales by Company
9.1.1 APAC Insulin Like Growth Factor I Sales Quantity by Company (2018-2023)
9.1.2 APAC Insulin Like Growth Factor I Revenue by Company (2018-2023)
9.2 APAC Insulin Like Growth Factor I Market Size by Type
9.2.1 APAC Insulin Like Growth Factor I Sales Quantity by Type (2018-2034)
9.2.2 APAC Insulin Like Growth Factor I Revenue by Type (2018-2034)
9.3 APAC Insulin Like Growth Factor I Market Size by Application
9.3.1 APAC Insulin Like Growth Factor I Sales Quantity by Application (2018-2034)
9.3.2 APAC Insulin Like Growth Factor I Revenue by Application (2018-2034)
9.4 APAC Insulin Like Growth Factor I Market Size by Region
9.4.1 APAC Insulin Like Growth Factor I Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Insulin Like Growth Factor I Revenue by Region (2018-2034)
9.4.3 APAC Insulin Like Growth Factor I Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Insulin Like Growth Factor I Sales by Company
10.1.1 Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Insulin Like Growth Factor I Market Size by Type
10.2.1 Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Insulin Like Growth Factor I Market Size by Application
10.3.1 Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Insulin Like Growth Factor I Market Size by Country
10.4.1 Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Company Information
11.1.2 Boehringer Ingelheim GmbH Overview
11.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Products and Services
11.1.5 Boehringer Ingelheim GmbH Insulin Like Growth Factor I SWOT Analysis
11.1.6 Boehringer Ingelheim GmbH Recent Developments
11.2 Genervon Biopharmaceuticals LLC
11.2.1 Genervon Biopharmaceuticals LLC Company Information
11.2.2 Genervon Biopharmaceuticals LLC Overview
11.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Products and Services
11.2.5 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I SWOT Analysis
11.2.6 Genervon Biopharmaceuticals LLC Recent Developments
11.3 MedImmune LLC
11.3.1 MedImmune LLC Company Information
11.3.2 MedImmune LLC Overview
11.3.3 MedImmune LLC Insulin Like Growth Factor I Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 MedImmune LLC Insulin Like Growth Factor I Products and Services
11.3.5 MedImmune LLC Insulin Like Growth Factor I SWOT Analysis
11.3.6 MedImmune LLC Recent Developments
11.4 Regulaxis SAS
11.4.1 Regulaxis SAS Company Information
11.4.2 Regulaxis SAS Overview
11.4.3 Regulaxis SAS Insulin Like Growth Factor I Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Regulaxis SAS Insulin Like Growth Factor I Products and Services
11.4.5 Regulaxis SAS Insulin Like Growth Factor I SWOT Analysis
11.4.6 Regulaxis SAS Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Insulin Like Growth Factor I Value Chain Analysis
12.2 Insulin Like Growth Factor I Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insulin Like Growth Factor I Production Mode & Process
12.4 Insulin Like Growth Factor I Sales and Marketing
12.4.1 Insulin Like Growth Factor I Sales Channels
12.4.2 Insulin Like Growth Factor I Distributors
12.5 Insulin Like Growth Factor I Customers
13 Market Dynamics
13.1 Insulin Like Growth Factor I Industry Trends
13.2 Insulin Like Growth Factor I Market Drivers
13.3 Insulin Like Growth Factor I Market Challenges
13.4 Insulin Like Growth Factor I Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of CIGB-845
Table 3. Major Manufacturers of Dusigitumab
Table 4. Major Manufacturers of GM-6
Table 5. Major Manufacturers of M-610.27
Table 6. Major Manufacturers of M-630
Table 7. Major Manufacturers of Others
Table 8. Global Insulin Like Growth Factor I Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Insulin Like Growth Factor I Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Insulin Like Growth Factor I Revenue by Region (2018-2023) & (US$ Million)
Table 11. Global Insulin Like Growth Factor I Revenue Market Share by Region (2018-2023)
Table 12. Global Insulin Like Growth Factor I Revenue by Region (2024-2034) & (US$ Million)
Table 13. Global Insulin Like Growth Factor I Revenue Market Share by Region (2024-2034)
Table 14. Global Insulin Like Growth Factor I Sales Quantity by Region: 2018 VS 2024 VS 2034 (K Pcs)
Table 15. Global Insulin Like Growth Factor I Sales by Region (2018-2023) & (K Pcs)
Table 16. Global Insulin Like Growth Factor I Sales Market Share by Region (2018-2023)
Table 17. Global Insulin Like Growth Factor I Sales by Region (2024-2034) & (K Pcs)
Table 18. Global Insulin Like Growth Factor I Sales Market Share by Region (2024-2034)
Table 19. Global Insulin Like Growth Factor I Sales Quantity by Manufacturers (2018-2023) & (K Pcs)
Table 20. Global Insulin Like Growth Factor I Sales Quantity Share by Manufacturers (2018-2023)
Table 21. Global Insulin Like Growth Factor I Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 22. Global Insulin Like Growth Factor I Revenue Share by Manufacturers (2018-2023)
Table 23. Global Insulin Like Growth Factor I Price by Manufacturers 2018-2023 (USD/Pcs)
Table 24. Global Key Players of Insulin Like Growth Factor I, Industry Ranking, 2021 VS 2024
Table 25. Global Insulin Like Growth Factor I Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Insulin Like Growth Factor I by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Like Growth Factor I as of 2024)
Table 27. Global Key Manufacturers of Insulin Like Growth Factor I, Manufacturing Base Distribution and Headquarters
Table 28. Global Key Manufacturers of Insulin Like Growth Factor I, Product Offered and Application
Table 29. Global Key Manufacturers of Insulin Like Growth Factor I, Date of Enter into This Industry
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Insulin Like Growth Factor I Sales Quantity by Type (2018-2023) & (K Pcs)
Table 32. Global Insulin Like Growth Factor I Sales Quantity by Type (2024-2034) & (K Pcs)
Table 33. Global Insulin Like Growth Factor I Sales Quantity Share by Type (2018-2023)
Table 34. Global Insulin Like Growth Factor I Sales Quantity Share by Type (2024-2034)
Table 35. Global Insulin Like Growth Factor I Revenue by Type (2018-2023) & (US$ Million)
Table 36. Global Insulin Like Growth Factor I Revenue by Type (2024-2034) & (US$ Million)
Table 37. Global Insulin Like Growth Factor I Revenue Share by Type (2018-2023)
Table 38. Global Insulin Like Growth Factor I Revenue Share by Type (2024-2034)
Table 39. Insulin Like Growth Factor I Price by Type (2018-2023) & (USD/Pcs)
Table 40. Global Insulin Like Growth Factor I Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 41. Global Insulin Like Growth Factor I Sales Quantity by Application (2018-2023) & (K Pcs)
Table 42. Global Insulin Like Growth Factor I Sales Quantity by Application (2024-2034) & (K Pcs)
Table 43. Global Insulin Like Growth Factor I Sales Quantity Share by Application (2018-2023)
Table 44. Global Insulin Like Growth Factor I Sales Quantity Share by Application (2024-2034)
Table 45. Global Insulin Like Growth Factor I Revenue by Application (2018-2023) & (US$ Million)
Table 46. Global Insulin Like Growth Factor I Revenue by Application (2024-2034) & (US$ Million)
Table 47. Global Insulin Like Growth Factor I Revenue Share by Application (2018-2023)
Table 48. Global Insulin Like Growth Factor I Revenue Share by Application (2024-2034)
Table 49. Insulin Like Growth Factor I Price by Application (2018-2023) & (USD/Pcs)
Table 50. Global Insulin Like Growth Factor I Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 51. North America Insulin Like Growth Factor I Revenue by Company (2018-2023) & (US$ Million)
Table 52. North America Insulin Like Growth Factor I Sales Quantity by Company (2018-2023) & (K Pcs)
Table 53. North America Insulin Like Growth Factor I Sales Quantity by Type (2018-2023) & (K Pcs)
Table 54. North America Insulin Like Growth Factor I Sales Quantity by Type (2024-2034) & (K Pcs)
Table 55. North America Insulin Like Growth Factor I Revenue by Type (2018-2023) & (US$ Million)
Table 56. North America Insulin Like Growth Factor I Revenue by Type (2024-2034) & (US$ Million)
Table 57. North America Insulin Like Growth Factor I Sales Quantity by Application (2018-2023) & (K Pcs)
Table 58. North America Insulin Like Growth Factor I Sales Quantity by Application (2024-2034) & (K Pcs)
Table 59. North America Insulin Like Growth Factor I Revenue by Application (2018-2023) & (US$ Million)
Table 60. North America Insulin Like Growth Factor I Revenue by Application (2024-2034) & (US$ Million)
Table 61. North America Insulin Like Growth Factor I Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 62. North America Insulin Like Growth Factor I Revenue by Country (2018-2023) & (US$ Million)
Table 63. North America Insulin Like Growth Factor I Revenue by Country (2024-2034) & (US$ Million)
Table 64. North America Insulin Like Growth Factor I Sales Quantity by Country (2018-2023) & (K Pcs)
Table 65. North America Insulin Like Growth Factor I Sales Quantity by Country (2024-2034) & (K Pcs)
Table 66. Europe Insulin Like Growth Factor I Sales Quantity by Company (2018-2023) & (K Pcs)
Table 67. Europe Insulin Like Growth Factor I Revenue by Company (2018-2023) & (US$ Million)
Table 68. Europe Insulin Like Growth Factor I Sales Quantity by Type (2018-2023) & (K Pcs)
Table 69. Europe Insulin Like Growth Factor I Sales Quantity by Type (2024-2034) & (K Pcs)
Table 70. Europe Insulin Like Growth Factor I Revenue by Type (2018-2023) & (US$ Million)
Table 71. Europe Insulin Like Growth Factor I Revenue by Type (2024-2034) & (US$ Million)
Table 72. Europe Insulin Like Growth Factor I Sales Quantity by Application (2018-2023) & (K Pcs)
Table 73. Europe Insulin Like Growth Factor I Sales Quantity by Application (2024-2034) & (K Pcs)
Table 74. Europe Insulin Like Growth Factor I Revenue by Application (2018-2023) & (US$ Million)
Table 75. Europe Insulin Like Growth Factor I Revenue by Application (2024-2034) & (US$ Million)
Table 76. Europe Insulin Like Growth Factor I Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 77. Europe Insulin Like Growth Factor I Revenue by Country (2018-2023) & (US$ Million)
Table 78. Europe Insulin Like Growth Factor I Revenue by Country (2024-2034) & (US$ Million)
Table 79. Europe Insulin Like Growth Factor I Sales Quantity by Country (2018-2023) & (K Pcs)
Table 80. Europe Insulin Like Growth Factor I Sales Quantity by Country (2024-2034) & (K Pcs)
Table 81. China Insulin Like Growth Factor I Sales Quantity by Company (2018-2023) & (K Pcs)
Table 82. China Insulin Like Growth Factor I Revenue by Company (2018-2023) & (US$ Million)
Table 83. China Insulin Like Growth Factor I Sales Quantity by Type (2018-2023) & (K Pcs)
Table 84. China Insulin Like Growth Factor I Sales Quantity by Type (2024-2034) & (K Pcs)
Table 85. China Insulin Like Growth Factor I Revenue by Type (2018-2023) & (US$ Million)
Table 86. China Insulin Like Growth Factor I Revenue by Type (2024-2034) & (US$ Million)
Table 87. China Insulin Like Growth Factor I Sales Quantity by Application (2018-2023) & (K Pcs)
Table 88. China Insulin Like Growth Factor I Sales Quantity by Application (2024-2034) & (K Pcs)
Table 89. China Insulin Like Growth Factor I Revenue by Application (2018-2023) & (US$ Million)
Table 90. China Insulin Like Growth Factor I Revenue by Application (2024-2034) & (US$ Million)
Table 91. APAC Insulin Like Growth Factor I Sales Quantity by Company (2018-2023) & (K Pcs)
Table 92. APAC Insulin Like Growth Factor I Revenue by Company (2018-2023) & (US$ Million)
Table 93. APAC Insulin Like Growth Factor I Sales Quantity by Type (2018-2023) & (K Pcs)
Table 94. APAC Insulin Like Growth Factor I Sales Quantity by Type (2024-2034) & (K Pcs)
Table 95. APAC Insulin Like Growth Factor I Revenue by Type (2018-2023) & (US$ Million)
Table 96. APAC Insulin Like Growth Factor I Revenue by Type (2024-2034) & (US$ Million)
Table 97. APAC Insulin Like Growth Factor I Sales Quantity by Application (2018-2023) & (K Pcs)
Table 98. APAC Insulin Like Growth Factor I Sales Quantity by Application (2024-2034) & (K Pcs)
Table 99. APAC Insulin Like Growth Factor I Revenue by Application (2018-2023) & (US$ Million)
Table 100. APAC Insulin Like Growth Factor I Revenue by Application (2024-2034) & (US$ Million)
Table 101. APAC Insulin Like Growth Factor I Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 102. APAC Insulin Like Growth Factor I Revenue by Region (2018-2023) & (US$ Million)
Table 103. APAC Insulin Like Growth Factor I Revenue by Region (2024-2034) & (US$ Million)
Table 104. APAC Insulin Like Growth Factor I Sales Quantity by Region (2018-2023) & (K Pcs)
Table 105. APAC Insulin Like Growth Factor I Sales Quantity by Region (2024-2034) & (K Pcs)
Table 106. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Company (2018-2023) & (K Pcs)
Table 107. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Company (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Type (2018-2023) & (K Pcs)
Table 109. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Type (2024-2034) & (K Pcs)
Table 110. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Type (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Type (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Application (2018-2023) & (K Pcs)
Table 113. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Application (2024-2034) & (K Pcs)
Table 114. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Application (2018-2023) & (US$ Million)
Table 115. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Application (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 117. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Country (2018-2023) & (US$ Million)
Table 118. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue by Country (2024-2034) & (US$ Million)
Table 119. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Country (2018-2023) & (K Pcs)
Table 120. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity by Country (2024-2034) & (K Pcs)
Table 121. Boehringer Ingelheim GmbH Company Information
Table 122. Boehringer Ingelheim GmbH Description and Overview
Table 123. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 124. Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product and Services
Table 125. Boehringer Ingelheim GmbH Insulin Like Growth Factor I SWOT Analysis
Table 126. Boehringer Ingelheim GmbH Recent Developments
Table 127. Genervon Biopharmaceuticals LLC Company Information
Table 128. Genervon Biopharmaceuticals LLC Description and Overview
Table 129. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 130. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product and Services
Table 131. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I SWOT Analysis
Table 132. Genervon Biopharmaceuticals LLC Recent Developments
Table 133. MedImmune LLC Company Information
Table 134. MedImmune LLC Description and Overview
Table 135. MedImmune LLC Insulin Like Growth Factor I Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 136. MedImmune LLC Insulin Like Growth Factor I Product and Services
Table 137. MedImmune LLC Insulin Like Growth Factor I SWOT Analysis
Table 138. MedImmune LLC Recent Developments
Table 139. Regulaxis SAS Company Information
Table 140. Regulaxis SAS Description and Overview
Table 141. Regulaxis SAS Insulin Like Growth Factor I Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2023)
Table 142. Regulaxis SAS Insulin Like Growth Factor I Product and Services
Table 143. Regulaxis SAS Insulin Like Growth Factor I SWOT Analysis
Table 144. Regulaxis SAS Recent Developments
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Insulin Like Growth Factor I Distributors List
Table 148. Insulin Like Growth Factor I Customers List
Table 149. Insulin Like Growth Factor I Market Trends
Table 150. Insulin Like Growth Factor I Market Drivers
Table 151. Insulin Like Growth Factor I Market Challenges
Table 152. Insulin Like Growth Factor I Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin Like Growth Factor I Product Picture
Figure 2. Global Insulin Like Growth Factor I Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Insulin Like Growth Factor I Market Share by Type in 2024 & 2034
Figure 4. CIGB-845 Product Picture
Figure 5. Dusigitumab Product Picture
Figure 6. GM-6 Product Picture
Figure 7. M-610.27 Product Picture
Figure 8. M-630 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Insulin Like Growth Factor I Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 11. Global Insulin Like Growth Factor I Market Share by Application in 2024 & 2034
Figure 12. Alzheimer's Disease
Figure 13. Breast Cancer
Figure 14. Huntington Disease
Figure 15. Muscular Dystrophy
Figure 16. Others
Figure 17. Insulin Like Growth Factor I Report Years Considered
Figure 18. Global Insulin Like Growth Factor I Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 19. Global Insulin Like Growth Factor I Revenue 2018-2034 (US$ Million)
Figure 20. Global Insulin Like Growth Factor I Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 21. Global Insulin Like Growth Factor I Sales Quantity 2018-2034 (K Pcs)
Figure 22. Global Insulin Like Growth Factor I Sales Quantity Market Share by Region (2018-2023)
Figure 23. Global Insulin Like Growth Factor I Sales Quantity Market Share by Region (2024-2034)
Figure 24. North America Insulin Like Growth Factor I Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 25. North America Insulin Like Growth Factor I Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Europe Insulin Like Growth Factor I Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 27. Europe Insulin Like Growth Factor I Revenue YoY (2018-2034) & (US$ Million)
Figure 28. China Insulin Like Growth Factor I Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 29. China Insulin Like Growth Factor I Revenue YoY (2018-2034) & (US$ Million)
Figure 30. APAC Insulin Like Growth Factor I Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 31. APAC Insulin Like Growth Factor I Revenue YoY (2018-2034) & (US$ Million)
Figure 32. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 33. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue YoY (2018-2034) & (US$ Million)
Figure 34. The Top 10 and Top 5 Players Market Share by Insulin Like Growth Factor I Sales Quantity in 2024
Figure 35. The Top 10 and Top 5 Players Market Share by Insulin Like Growth Factor I Revenue in 2024
Figure 36. Insulin Like Growth Factor I Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 37. Global Insulin Like Growth Factor I Sales Quantity Market Share by Type (2018-2034)
Figure 38. Global Insulin Like Growth Factor I Revenue Market Share by Type (2018-2034)
Figure 39. Global Insulin Like Growth Factor I Sales Quantity Market Share by Application (2018-2034)
Figure 40. Global Insulin Like Growth Factor I Revenue Market Share by Application (2018-2034)
Figure 41. North America Insulin Like Growth Factor I Revenue Market Share by Company in 2024
Figure 42. North America Insulin Like Growth Factor I Sales Quantity Market Share by Company in 2024
Figure 43. North America Insulin Like Growth Factor I Sales Quantity Market Share by Type (2018-2034)
Figure 44. North America Insulin Like Growth Factor I Revenue Market Share by Type (2018-2034)
Figure 45. North America Insulin Like Growth Factor I Sales Quantity Market Share by Application (2018-2034)
Figure 46. North America Insulin Like Growth Factor I Revenue Market Share by Application (2018-2034)
Figure 47. North America Insulin Like Growth Factor I Revenue Share by Country (2018-2034)
Figure 48. North America Insulin Like Growth Factor I Sales Quantity Share by Country (2018-2034)
Figure 49. U.S. Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 50. Canada Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 51. Europe Insulin Like Growth Factor I Sales Quantity Market Share by Company in 2024
Figure 52. Europe Insulin Like Growth Factor I Revenue Market Share by Company in 2024
Figure 53. Europe Insulin Like Growth Factor I Sales Quantity Market Share by Type (2018-2034)
Figure 54. Europe Insulin Like Growth Factor I Revenue Market Share by Type (2018-2034)
Figure 55. Europe Insulin Like Growth Factor I Sales Quantity Market Share by Application (2018-2034)
Figure 56. Europe Insulin Like Growth Factor I Revenue Market Share by Application (2018-2034)
Figure 57. Europe Insulin Like Growth Factor I Revenue Share by Country (2018-2034)
Figure 58. Europe Insulin Like Growth Factor I Sales Quantity Share by Country (2018-2034)
Figure 59. Germany Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 60. France Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 61. U.K. Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 62. Italy Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 63. Russia Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 64. China Insulin Like Growth Factor I Sales Quantity Market Share by Company in 2024
Figure 65. China Insulin Like Growth Factor I Revenue Market Share by Company in 2024
Figure 66. China Insulin Like Growth Factor I Sales Quantity Market Share by Type (2018-2034)
Figure 67. China Insulin Like Growth Factor I Revenue Market Share by Type (2018-2034)
Figure 68. China Insulin Like Growth Factor I Sales Quantity Market Share by Application (2018-2034)
Figure 69. China Insulin Like Growth Factor I Revenue Market Share by Application (2018-2034)
Figure 70. APAC Insulin Like Growth Factor I Sales Quantity Market Share by Company in 2024
Figure 71. APAC Insulin Like Growth Factor I Revenue Market Share by Company in 2024
Figure 72. APAC Insulin Like Growth Factor I Sales Quantity Market Share by Type (2018-2034)
Figure 73. APAC Insulin Like Growth Factor I Revenue Market Share by Type (2018-2034)
Figure 74. APAC Insulin Like Growth Factor I Sales Quantity Market Share by Application (2018-2034)
Figure 75. APAC Insulin Like Growth Factor I Revenue Market Share by Application (2018-2034)
Figure 76. APAC Insulin Like Growth Factor I Revenue Share by Region (2018-2034)
Figure 77. APAC Insulin Like Growth Factor I Sales Quantity Share by Region (2018-2034)
Figure 78. Japan Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 79. South Korea Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 80. China Taiwan Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 81. Southeast Asia Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 82. India Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 83. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity Market Share by Company in 2024
Figure 84. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue Market Share by Company in 2024
Figure 85. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity Market Share by Type (2018-2034)
Figure 86. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity Market Share by Application (2018-2034)
Figure 88. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America Insulin Like Growth Factor I Sales Quantity Share by Country (2018-2034)
Figure 90. Middle East, Africa and Latin America Insulin Like Growth Factor I Revenue Share by Country (2018-2034)
Figure 91. Brazil Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 92. Mexico Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 93. Turkey Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 94. Israel Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 95. GCC Countries Insulin Like Growth Factor I Revenue (2018-2034) & (US$ Million)
Figure 96. Insulin Like Growth Factor I Value Chain
Figure 97. Insulin Like Growth Factor I Production Process
Figure 98. Channels of Distribution (Direct Vs Distribution)
Figure 99. Distributors Profiles
Figure 100. Bottom-up and Top-down Approaches for This Report
Figure 101. Data Triangulation
Figure 102. Key Executives Interviewed